Metraipolis › archive › dc_7bc458f26cb8

Development and optimization of Moxifloxacin solid lipid nanoparticles via double emulsion organic solvent free technique applying Box-Behnken experimental… — Europe PMC PMID:41291000

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41291000
DOI
10.1038/s41598-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-08T06:25:54.541Z
SHA-256 of the archived text
6b7c727a3e51147e8b253c63eadca1ab3a23509ff4bdcbb50901fd5e2b1943a7
Stable URL of this page
https://metraipolis.com/documento/dc_7bc458f26cb8

How to cite

Development and optimization of Moxifloxacin solid lipid nanoparticles via double emulsion organic solvent free technique applying Box-Behnken experimental… — Europe PMC PMID:41291000 — Europe PMC (en), https://europepmc.org/article/MED/41291000 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7bc458f26cb8 (Metraipolis archive dc_7bc458f26cb8, sha256 6b7c727a3e51147e8b253c63eadca1ab3a23509ff4bdcbb50901fd5e2b1943a7)
BibTeX
@misc{dc7bc458f26cb8,
  title = {Development and optimization of Moxifloxacin solid lipid nanoparticles via double emulsion organic solvent free technique applying Box-Behnken experimental… — Europe PMC PMID:41291000},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41291000},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7bc458f26cb8; sha256 6b7c727a3e51147e8b253c63eadca1ab3a23509ff4bdcbb50901fd5e2b1943a7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41291000. Agents can read the archived copy with the MCP tool read_document.